Co-Authors
This is a "connection" page, showing publications co-authored by MARIA KRISTINE GULE-MONROE and STEPHEN YENZEN LAI.
Connection Strength
0.525
-
Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model. Clin Cancer Res. 2011 Apr 15; 17(8):2281-91.
Score: 0.384
-
Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series. Thyroid. 2023 01; 33(1):129-132.
Score: 0.055
-
Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma. Thyroid. 2019 08; 29(8):1036-1043.
Score: 0.043
-
Incidental detection of oropharyngeal cancer with fluciclovine PET. Head Neck. 2019 08; 41(8):E141-E145.
Score: 0.043